John Hare has spent nearly 30 years developing Meggabiotics – a groundbreaking platform using IGY antibodies from hen eggs to treat and prevent human gut infections like C. difficile. His oral, egg-based treatment is safe, simple, and inexpensive to produce. So why isn’t it on the market? In this candid video, John explains how the current FDA regulatory system forces every new treatment – no matter how safe – through the same $1–3 billion approval gauntlet as complex oncology drugs. The result? Low-cost, low-risk cures never reach patients. John connects this to the MAHA (Make America Healthy Again) movement and proposes a radical but logical fix: The FDA should only regulate safety. Let companies prove effectiveness to the public.
